KPMG-INTERNATIONAL
14.10.2020 06:03:13 CEST | Business Wire | Press release
As General Counsel and in-house legal teams contend with the increasing pressures facing their organizations in the wake of COVID-19, there is an urgent need to rethink delivery models and transform legal function operations. While the move to digitize and automate the legal function was already underway before COVID-19, it is now a commercial imperative, and the scope and remit is wider than before as the pandemic situation has intensified the need for organizations to transform.
In response, a Global Legal Operations Transformation Services offering has been launched across KPMG firms, which is designed to provide clients with a wide range of global strategies and cross-border capabilities to help meet the challenges they face.
“I believe KPMG’s Global Legal Operations Transformation Services teams are ‘global,’ both in terms of the geographic coverage but also the strategies offered,” says Stuart Fuller , Head of Global Legal Services, KPMG International. “Practice leaders are senior, experienced, and work together in KPMG firms across Europe, the Americas and the Asia Pacific region. They have a laser focus on results, and they are delivering significant and measurable improvement for legal functions across KPIs, such as productivity, customer satisfaction and quality measures―results that are crucial for organizations in the current climate.”
The KPMG Legal Operations Transformation Services practice leadership team includes Andreas Bong , Nicola Brooks , Philipp Glock , Eric Gorman , Kimberly Tan Majure and David Murray , and with an imminent announcement of a significant further partner hire. These leaders are supported by their team members in country firms, and professionals across the global organization, including MBAs, lawyers, legal technologists, data scientists and specialists in operational excellence. Their diverse and complementary skillsets, and combined experience, unite under KPMG’s global methodology to provide significant value to clients.
“We draw on all of the strengths of KPMG professionals across our firms, not just in legal and technology, but also Lean Six Sigma, Human-Centred Design and Systems Thinking. Together, our organization has achieved a substantial track record of implementing and running the transformation opportunities that we identify,” says Fuller. “KPMG Law is a combination of skills and approaches: we have over 2,700 lawyers in 81 jurisdictions advising on complex advisory and regulatory matters, and large transactions; we also provide global solutions such as business reorganization, global entity management and mass claims, offering an integrated service and advice. The new Legal Operations Transformation Service enables KPMG firms to handle large-scale business in a more efficient and technologically-enabled way and is only the first in a number of capabilities and services that we plan to provide in this space.”
The Legal Operations Transformation Services team brings more than 14 years of credentials and experience in the legal transformation space, with recent and current engagements across multinational organizations in the financial services, asset management, automotive, insurance and consumer goods sectors. In the past two years alone, KPMG firms have delivered cost savings of more than US$200 million across a range of services, including process optimization, automation, contract life cycle management, managed services and productized legal solutions.
David Linke , the Global Head of Tax & Legal Services for KPMG International, says “KPMG firms have a record of innovation and success in Tax Transformation under the banner of ’Tax Reimagined.’ Legal Operations Transformation Services are one of KPMG firms’ leading service offerings. While COVID-19 has accelerated the trends that we were already seeing for legal transformation, the post-COVID world will require legal and compliance teams to be even more efficient, even more engaged with the business and to play a key role in driving the customer experience, revenue and cash conversion cycles. Never has a global and integrated approach to transformation been more in demand than in the current climate. KPMG professionals are focused on bringing the best of our global capabilities, expertise and solutions to legal departments.”
* Important note: Certain member firms of the KPMG global organization, including the US firm, KPMG LLP, do not provide legal services or have KPMG Law service entities. In the US, these Legal Operations Transformation Services will be provided through the Advisory and Tax functions. Some or all the services described herein may not be permissible for KPMG audit clients and their affiliates or related entities.
About KPMG International
KPMG is a global organization of independent professional services firms providing Audit, Tax and Advisory services. We operate in 147 countries and territories and have more than 219,000 people working in member firms around the world. Each KPMG firm is a legally distinct and separate entity and describes itself as such.
KPMG International Limited is a private English company limited by guarantee. KPMG International Limited and its related entities do not provide services to clients.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201013006153/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
